Apellis Pharmaceuticals Inc. (NAS) Delayed quote data. 2/23/2024 04:00 PM: hide quote: detailed quote: options chain: add to favorites: list favorites: chart help: Last: 68.47. Change: +0.88. Open: 67.49. High: 68.73. Low: 67.02. ... Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 …Find the latest Apellis Pharmaceuticals, Inc. (APLS) stock quote, history, news and other vital information to help you with your stock trading and investing.In related news, insider Lukas Scheibler sold 10,000 shares of Apellis Pharmaceuticals stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $60.00, for a ...Future criteria checks 5/6. Apellis Pharmaceuticals is forecast to grow earnings and revenue by 59.3% and 31.4% per annum respectively. EPS is expected to grow by 59.9% per annum. Return on equity is forecast to be 7.6% in 3 years.See insights on Apellis Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. ... Financials; Operating Metrics; Human Capital; Key People; Competitors; Supplier Risk; Apellis Pharmaceuticals. Stock Price. $67.4. 2024-02-14. Market Capitalization. $8 B. 2024-02 …NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 66.89-0.96 (-1.41%) ... Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses ...Find the latest Apellis Pharmaceuticals, Inc. (1JK.F) stock quote, history, news and other vital information to help you with your stock trading and investing.APLS Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Pharmaceuticals. APELLIS PHARMACEUTICALS, INC. (APLS) Compare. APELLIS PHARMACEUTICALS, ... Apellis Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time APLS stock price. MT. Apellis Pharmaceuticals Insider Sold Shares Worth $469,905, According to a Recent SEC Filing. Jan. 24. MT. Needham Adjusts Price Target on Apellis Pharmaceuticals to $75 From $70, Maintains Buy Rating. Jan. 24. MT. Apellis Pharmaceuticals Insider Sold Shares Worth $872,961, According to a Recent SEC Filing. Jan. 24. What is Apellis Pharmaceuticals Inc(APLS)'s stock price today? The current price of APLS is $68.51. The 52 week high of APLS is $94.75 and 52 week low is $19.83 ...Real time Apellis Pharmaceuticals (APLS) stock price quote, stock graph, news & analysis. Complete Apellis Pharmaceuticals Inc. stock information by Barron's. View real-time APLS stock price and news, along with industry-best analysis. The Apellis Pharmaceuticals, Inc. stock price is closed at $ 59.61 with a total market cap valuation of $ 7.06B (118.50M shares outstanding). The Apellis Pharmaceuticals, Inc. is trading on NASDAQ with the sign APLS. Apellis Pharmaceuticals, Inc. price is up -1.84% in the past 24 hours.In today’s rapidly advancing healthcare industry, pharmaceutical companies play a crucial role in developing and manufacturing life-saving drugs and medical devices. Pfizer Inc. is...You can buy and sell Apellis Pharmaceuticals (APLS) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. WALTHAM, Mass., April 23, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced post hoc analyses from the 24-month, Phase 3 OAKS and DERBY studies evaluating SYFOVRE™ (pegcetacoplan injection) for the treatment of geographic …Feb 14, 2024 · The latest price target for Apellis Pharmaceuticals ( NASDAQ: APLS) was reported by Baird on Tuesday, February 6, 2024. The analyst firm set a price target for 81.00 expecting APLS to rise to ... Get Our Latest Stock Analysis on Apellis Pharmaceuticals Apellis Pharmaceuticals Stock Performance. NASDAQ APLS opened at $68.47 on Friday. The …5 days ago · Apellis Pharmaceuticals, Inc. 67.33. -1.45. -2.11%. Among the Magnificent Seven stocks to buy and watch, Apple, Nvidia and Tesla stock are in new buy areas. Intel has numerous growth opportunities ... Apellis Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.Evolution of the average Target Price on Apellis Pharmaceuticals, Inc. Price target over the last 5 years. History of analyst recommendation changes. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ +229% on MICROSOFT CORPORATION since our purchase on January 11, 2019.Apellis Pharmaceuticals (APLS) Quote Overview » Zacks Research » Apellis Pharmaceuticals (APLS) Style Scores Better trading starts here. Apellis Pharmaceuticals, Inc. - HoldStock Price Forecast. The 18 analysts with 12-month price forecasts for APLS stock have an average target of 78.17, with a low estimate of 46 and a high ...Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application. WALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European …The average Apellis Pharmaceuticals stock price prediction forecasts a potential upside of 9.58% from the current APLS share price of $67.59. What is APLS's ...APLS | Complete Apellis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Apellis Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.Apellis price target raised to $110 from $106 at Raymond James February 5, 2024TipRanks. Get Apellis Pharmaceuticals Inc (APLS:NASDAQ) real-time stock quotes, news, price and financial information ...Apellis Pharmaceuticals trades on the NASDAQ stock market under the symbol APLS. What is Apellis Pharmaceuticals stock price doing today? As of February 2, 2024, APLS stock price climbed to $62.56 with 883,771 million shares trading. APLS is currently covered by 18 analysts with an average price target of $81.97. This is a potential upside of $15.76 (23.8%) from yesterday's end of day stock price of $66.21. Apellis Pharmaceuticals's activity chart (see below) currently has 131 price targets and 177 ratings on display.As of December 1, 2023, Apellis Pharmaceuticals Inc’s stock price is $61.58, which is up 14.31% from its previous closing price. AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Apellis Pharmaceuticals Inc stock prices are …A high-level overview of Apellis Pharmaceuticals, Inc. (APLS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. View the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, historical charts, analyst ratings and financial information from WSJ.Apellis Pharmaceuticals (APLS) Stock Forecast & Price Target-- Apellis Pharmaceuticals has an average outperform rating and price target range of $44 to $95, according to analysts polled by Capital IQ. Price: 48.00, Change: -14.88, Percent Change: -23.66 ...Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2021-11-17 - 2 views Apellis Announces Closing of Previously Announced Exchanges of Approximately $201.1 Million in Principal Amount of Its 3.500% Convertible Senior Notes Due 2026 for Common Stock 2021-07-26 - 5 viewsOur goal is to transform treatment for a broad range of debilitating diseases by controlling a part of the immune system known as the complement cascade. We ushered in the first new class of complement medicine in 15 years, and now have two approved medicines targeting C3, the central protein in the cascade. These include the first-ever therapy ...NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 66.89-0.96 (-1.41%) ... Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses ...Apellis price target raised to $110 from $106 at Raymond James February 5, 2024TipRanks. Get Apellis Pharmaceuticals Inc (APLS:NASDAQ) real-time stock quotes, news, price and financial information ...India, known for its rich cultural heritage and diverse traditions, is also a powerhouse when it comes to export industries. The country has a strong presence in several sectors, r...View the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, historical charts, analyst ratings and financial information from WSJ. MT. Apellis Pharmaceuticals Insider Sold Shares Worth $469,905, According to a Recent SEC Filing. Jan. 24. MT. Needham Adjusts Price Target on Apellis Pharmaceuticals to $75 From $70, Maintains Buy Rating. Jan. 24. MT. Apellis Pharmaceuticals Insider Sold Shares Worth $872,961, According to a Recent SEC Filing. Jan. 24. Feb 16, 2024 · According to the current price, Apellis Pharmaceuticals is 346.95% away from the 52-week low. What was the 52-week high for Apellis Pharmaceuticals stock? The high in the last 52 weeks of Apellis ... View the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, historical charts, analyst ratings and financial information from WSJ. The PE Ratio as of February 2024 (TTM) for Apellis Pharmaceuticals, Inc. ( APLS) is -12.93. According to Apellis Pharmaceuticals, Inc. ’s latest financial reports and current stock price. The company's current PE Ratio is -12.93. This represents a change of 4.51% compared to the average of -12.37 of the last 4 quarters.News for Apellis Pharmaceuticals Inc Registered Shs ... US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets ...Apellis Pharmaceuticals, Inc. Common Stock (APLS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Apellis Pharmaceuticals, Inc. Common Stock (APLS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.In depth view into APLS (Apellis Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Apellis Pharmaceuticals Inc …Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...Apellis Pharmaceuticals, Inc. (APLS) Stock Price, News, Quote & History - Yahoo Finance Industry News Canada markets close in 3 hours 54 minutes S&P/TSX …In related news, insider Lukas Scheibler sold 10,000 shares of Apellis Pharmaceuticals stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $60.00, for a ...News for Apellis Pharmaceuticals Inc. Thursday, December 14, 2023. 07:15 AM ET. Apellis Pharmaceuticals’ stock slides 14% after company gets negative trend vote for eye treatment in Europe MarketWatch. Friday, October 06, 2023. 06:25 AM ET. Apellis Pharmaceuticals upgraded to overweight from neutral at J.P. Morgan …The upgrade of Apellis Pharmaceuticals, Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in ... Stock Price, News, Quote and Profile of APELLIS PHARMACEUTICALS INC(NASDAQ:APLS) stock. General stock ratings, overview and activity description.The Apellis Pharmaceuticals stock prediction for 2025 is currently $ 88.93, assuming that Apellis Pharmaceuticals shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 29.88% increase in the APLS stock price. Apellis Pharmaceuticals Stock Prediction 2030 Apellis Pharmaceuticals Inc share price live 68.16, this page displays NASDAQ APLS stock exchange data. View the APLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Apellis Pharmaceuticals Inc real time stock price chart ...Get Our Latest Stock Analysis on Apellis Pharmaceuticals Apellis Pharmaceuticals Stock Performance. NASDAQ APLS opened at $68.47 on Friday. The …-- Apellis Pharmaceuticals has an average outperform rating and price target range of $44 to $95, according to analysts polled by Capital IQ. Price: 48.00, Change: -14.88, Percent Change: -23.66 ...You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...According to analysts' consensus price target of $75.93, Apellis Pharmaceuticals has a forecasted upside of 10.9% from its current price of $68.47. Amount of ...Apellis Pharmaceuticals Inc stock price (APLS) NASDAQ: APLS. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Apellis Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Get the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Apellis Pharmaceuticals (APLS) Stock Forecast & Price TargetThe latest closing stock price for Apellis Pharmaceuticals as of February 05, 2024 is 68.16. The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on June 13, 2023. The Apellis Pharmaceuticals 52-week high stock price is 94.75, which is 39% above the current share price. The Apellis Pharmaceuticals 52-week low stock price …Apellis Pharmaceuticals has a strong track record of developing innovative therapies for patients with unmet medical needs. Find out why APLS stock is a speculative buy.Citi analyst Yigal Nochomovitz maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report) on December 1 and set a price target of $70.00.. Yigal Nochomovitz’s Buy rating for ...5 days ago · Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. UNATTRACTIVE: Apellis Pharmaceuticals exhibits a price/book ratio which exceeds the industry average for drugs stocks listed on the NASDAQ. Price / Book explained. Price / Earnings. 0.1 . 0.0 . ... Why Apellis Pharmaceuticals Stock Surged This Week. February 24th, 2023 - Motley Fool.View live Apellis Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, APLS financials and market news.Short interest for Apellis Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Apellis Pharmaceuticals 's stock. Short interest data is updated ...Related news Stock Upgrades: Apellis Pharmaceuticals Shows Rising Relative Strength. 1/29/2024 Apellis Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative ...Apellis Pharmaceuticals Inc stock price live 64.04, this page displays NASDAQ APLS stock exchange data. View the APLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Apellis Pharmaceuticals Inc real time stock price chart below. You can find more details by …These 21 analysts have an average price target of $65.0 versus the current price of Apellis Pharmaceuticals at $51.075, implying upside. Below is a summary of how these 21 analysts rated Apellis ...Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Find the latest Apellis Pharmaceuticals Inc (1JK.SG) stock quote, history, news and other vital information to help you with your stock trading and investing.Common stock, $0.0001 par value; 200,000 shares authorized at December 31, 2022 and 2021; 110,772 and 97,524 shares issued and outstanding at December 31, 2022 and 2021 ... 760,217 $ 881,765 APELLIS PHARMACEUTICALS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Amounts in …Apellis pharmaceuticals stock price
Jan 26, 2024 · Jan 08, 2024 Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues. Dec 14, 2023 8:30 AM EST. Click here for webcast. Investor Contact. Meredith Kaya. (617) 599-8178. [email protected]. Lissa Pavluk. (617) 977-6764. Get Apellis Pharmaceuticals Inc (APLS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsJan 26, 2024 · Jan 08, 2024 Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues. Dec 14, 2023 8:30 AM EST. Click here for webcast. Investor Contact. Meredith Kaya. (617) 599-8178. [email protected]. Lissa Pavluk. (617) 977-6764. Apellis Pharmaceuticals Inc’s Stock Price as of Market Close. As of July 20, 2023, 4:00 PM CST, Apellis Pharmaceuticals Inc’s stock price was $34.24. Apellis Pharmaceuticals Inc is down 15.44% from its previous closing price of $40.49. During the last market session, Apellis Pharmaceuticals Inc’s stock traded between $38.50 and …Throughout the day, the stock experienced a range of prices, fluctuating between $41.20 and $46.00. The trading volume for the day was 380,682. As of November 6, 2023, the market capitalization of Apellis Pharmaceuticals Inc. stood at $5.6 billion. In terms of earnings growth, Apellis Pharmaceuticals Inc. has shown positive performance.Feb 16, 2024 · What was Apellis Pharmaceuticals Inc’s price range in the past 12 months? Apellis Pharmaceuticals Inc lowest stock price was $19.83 and its highest was $94.75 in ... Find the latest dividend history for Apellis Pharmaceuticals, Inc. Common Stock (APLS) at Nasdaq.com.Nov 29, 2023 ... As of November 29, 2023, 4:00 PM, CST, Apellis Pharmaceuticals Inc's stock price was $50.30. Apellis Pharmaceuticals Inc is up 6.66% from its ...Apellis Pharmaceuticals, Inc. Common Stock (APLS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Apellis Pharmaceuticals Inc stock price live 64.04, this page displays NASDAQ APLS stock exchange data. View the APLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Apellis Pharmaceuticals Inc real time stock price chart below. You can find more details by …View the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, historical charts, analyst ratings and financial information from WSJ. This price target is based on 15 analysts offering 12 month price targets for Apellis Pharmaceuticals in the last 3 months. The average price target is $75.93, with a high forecast of $106.00 and a low forecast of $54.00.Cost of Sales. Cost of sales were $5.6 million and $0.2 million for the full year 2022 and 2021, respectively. ... APELLIS PHARMACEUTICALS, INC. ... Preferred stock, $0.0001 par value; 10,000 shares authorized and zero shares issued and outstanding at December 31, 2022 and 2021 ...Jan 9, 2024 · Apellis Pharmaceuticals, Inc. (APLS) shares ended the last trading session 14.7% higher at $68.35. The jump came on an impressive volume with a higher-than-average number of shares changing hands ... Feb 24, 2023 ... Apellis investors reaped the benefits of that approval this week, namely a stock surge that saw the company's share price jump 19% this week, ...WALTHAM, Mass. and CRESTWOOD, Ky., March 07, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, today announced the …Throughout the day, the stock experienced a range of prices, fluctuating between $41.20 and $46.00. The trading volume for the day was 380,682. As of November 6, 2023, the market capitalization of Apellis Pharmaceuticals Inc. stood at $5.6 billion. In terms of earnings growth, Apellis Pharmaceuticals Inc. has shown positive performance.Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...The stock's price-to-GF-Value ratio stands at 0.45, with a GuruFocus Value of $144.67, indicating that Apellis Pharmaceuticals Inc is currently categorized as a Possible Value Trap, Think Twice ...Apellis Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time APLS stock price. Short interest for Apellis Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Apellis Pharmaceuticals 's stock. Short interest data is updated ...Apellis Pharmaceuticals has a strong track record of developing innovative therapies for patients with unmet medical needs. Find out why APLS stock is a speculative buy.Apellis Pharmaceuticals, Inc. (APLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Find the latest Apellis Pharmaceuticals Inc (1JK.SG) stock quote, history, news and other vital information to help you with your stock trading and investing.View the basic APLS option chain and compare options of Apellis Pharmaceuticals, Inc. on Yahoo Finance.Apellis Pharmaceuticals (APLS) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.Oct 31, 2023 ... Real-time quote and/or trade prices are not sourced from all markets. APLS Earnings. Apellis Pharmaceuticals showed 0% EPS ...The last closing price for Apellis Pharmaceuticals was US$68.12. Over the last year, Apellis Pharmaceuticals shares have traded in a share price range of US ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...Apellis Pharmaceuticals Stock Forecast. All Analysts Top Analysts Stock Price Forecast. The 18 analysts with 12-month price forecasts for APLS stock have an average target of 77.17, with a low estimate of 42 and a high estimate of 141.The latest closing stock price for Apellis Pharmaceuticals as of February 05, 2024 is 68.16. The all-time high Apellis Pharmaceuticals stock closing price was 93.31 on …3 days ago · The Apellis Pharmaceuticals Inc. stock price gained 0.646% on the last trading day (Friday, 9th Feb 2024), rising from $68.12 to $68.56. During the last trading day the stock fluctuated 1.89% from a day low at $68.11 to a day high of $69.40. The price has risen in 6 of the last 10 days and is up by 7.06% over the past 2 weeks. Stock analysis for Apellis Pharmaceuticals Inc (APLS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...Apellis Pharmaceuticals, Inc. Common Stock (APLS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Apellis Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time APLS stock price. Upgrades. $34 → $64. -5.03%. Sep 15, 2023. Show More Ratings. A list of analyst ratings for Apellis Pharmaceuticals (APLS) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts.In depth view into APLS (Apellis Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Oct 31, 2023 ... Real-time quote and/or trade prices are not sourced from all markets. APLS Earnings. Apellis Pharmaceuticals showed 0% EPS ...Apellis Pharmaceuticals, Inc. Common Stock (APLS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Apellis Pharmaceuticals Inc. (NAS) Delayed quote data. 2/23/2024 04:00 PM: hide quote: detailed quote: options chain: add to favorites: list favorites: chart help: Last: 68.47. Change: +0.88. Open: 67.49. High: 68.73. Low: 67.02. ... Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 …Nov 9, 2017 · 1:1. February 15, 2024. $67.99. $68.65. $66.87. $67.58. 1,030,533. 1:1. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. Apellis Pharmaceuticals Inc stock price (APLS) NASDAQ: APLS. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Apellis Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Complete Apellis Pharmaceuticals Inc. stock information by Barron's. View real-time APLS stock price and news, along with industry-best analysis. Apellis Pharmaceuticals Price Performance. Shares of APLS opened at $68.47 on Friday. The firm has a market cap of $8.11 billion, a PE ratio of -13.04 and a beta of 0.93. The firm's 50 day moving average price is $64.53 and its 200 day moving average price is $52.06.Get Our Latest Stock Analysis on Apellis Pharmaceuticals Apellis Pharmaceuticals Stock Performance. NASDAQ APLS opened at $68.47 on Friday. The …The PE Ratio as of February 2024 (TTM) for Apellis Pharmaceuticals, Inc. ( APLS) is -12.93. According to Apellis Pharmaceuticals, Inc. ’s latest financial reports and current stock price. The company's current PE Ratio is -12.93. This represents a change of 4.51% compared to the average of -12.37 of the last 4 quarters.Get Our Latest Stock Analysis on Apellis Pharmaceuticals Apellis Pharmaceuticals Stock Performance. NASDAQ APLS opened at $68.47 on Friday. The stock has a market capitalization of $8.11 billion, a price-to-earnings ratio of -13.04 and a beta of 0.93. Apellis Pharmaceuticals has a twelve month low of $19.83 and a twelve …UNATTRACTIVE: Apellis Pharmaceuticals exhibits a price/book ratio which exceeds the industry average for drugs stocks listed on the NASDAQ. Price / Book explained. Price / Earnings. 0.1 . 0.0 . ... Why Apellis Pharmaceuticals Stock Surged This Week. February 24th, 2023 - Motley Fool.Discover historical prices for APLS stock on Yahoo Finance. View daily, weekly or monthly format back to when Apellis Pharmaceuticals, Inc. stock was issued. Home. Mail; News; Sports; Finance; ... Apellis Pharmaceuticals, Inc. (APLS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. 70.23 +4.14 (+6.26%)View the latest Apellis Pharmaceuticals Inc. (APLS) stock price, news, historical charts, analyst ratings and financial information from WSJ. These 21 analysts have an average price target of $65.0 versus the current price of Apellis Pharmaceuticals at $51.075, implying upside. Below is a summary of how these 21 analysts rated Apellis ...Apellis price target raised to $110 from $106 at Raymond James February 5, 2024TipRanks. Get Apellis Pharmaceuticals Inc (APLS:NASDAQ) real-time stock quotes, news, price and financial information ...Feb 23, 202406:27 PST. Investors are always looking for stocks that are poised to beat at earnings season and Apellis Pharmaceuticals, Inc. APLS may be one …Feb 16, 2024 · What was Apellis Pharmaceuticals Inc’s price range in the past 12 months? Apellis Pharmaceuticals Inc lowest stock price was $19.83 and its highest was $94.75 in ... With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc.... Soft sparkling